Human medicines European public assessment report (EPAR): Deferasirox Mylan, deferasirox, Date of authorisation: 26/09/2019, Revision: 11, Status: Authorised

Handling competing interests

Data protection and privacy at EMA

Regulatory acceptance of new approach methodologies (NAMs) to reduce animal use testing

Small and medium-sized enterprise (SME) office annual report 2024

Policy 58: European Medicines Agency policy on the handling of competing interests of Management Board members

Policy 44: European Medicines Agency policy on the handling of competing interests of scientific committees’ members and experts

List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)

Report - Industry stakeholders and EU network experts surveys on early engagement fostering innovation

Herbal medicinal product: Uvae ursi folium, Arctostaphylos uva-ursi (L.) Spreng., C: ongoing call for scientific data